Celltrion Unfazed by U.S. Price Cuts, Tariffs Zymfentra Drag Tied to Insurance 송영두 2025.05.15 오후 03:23 Huons sees limited impact on its exports from Trump’s executive order aiming at lowering drug pr... 신민준 2025.05.14 오전 09:19 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 Celltrion Sees Opportunity in Trump Drug Pricing Order 김승권 2025.05.13 오후 03:16 Trump Signs Executive Order to Cut Drug Prices…Benefits for Korean biosimilars? 김새미 2025.04.17 오전 09:11 "바이 아메리카 최대 수혜주"...엑세스바이오, 2782억 美국방부 수주는 신호탄 김지완 2022.12.22 오전 08:50 로딩중..